36.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$35.73
Offen:
$35.63
24-Stunden-Volumen:
539.93K
Relative Volume:
0.56
Marktkapitalisierung:
$2.06B
Einnahmen:
$2.00B
Nettoeinkommen (Verlust:
$-119.19M
KGV:
-16.47
EPS:
-2.19
Netto-Cashflow:
$-61.88M
1W Leistung:
+9.11%
1M Leistung:
+15.73%
6M Leistung:
-22.25%
1J Leistung:
-30.92%
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Vergleichen Sie ENOV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ENOV
Enovis Corp
|
36.06 | 1.89B | 2.00B | -119.19M | -61.88M | -2.19 |
![]()
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-06-13 | Eingeleitet | JP Morgan | Neutral |
2024-02-13 | Eingeleitet | Stephens | Overweight |
2024-01-22 | Eingeleitet | UBS | Buy |
2024-01-03 | Eingeleitet | William Blair | Outperform |
2023-12-15 | Bestätigt | Needham | Buy |
2023-10-20 | Eingeleitet | ROTH MKM | Buy |
2023-06-26 | Eingeleitet | Needham | Buy |
2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-10-12 | Eingeleitet | Jefferies | Buy |
2022-10-11 | Eingeleitet | Goldman | Buy |
2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
2022-06-28 | Eingeleitet | Argus | Hold |
2022-06-27 | Fortgesetzt | Loop Capital | Buy |
2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) - Yahoo Finance
Canaccord cuts Enovis stock target to $70, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Enovis stock target to $70, maintains Buy rating - Investing.com Australia
Enovis (ENOV): Canaccord Genuity Lowers Price Target to $70 | EN - GuruFocus
Canaccord Adjusts Price Target for Enovis (ENOV) Following Q1 Re - GuruFocus
Enovis price target lowered to $70 from $75 at Canaccord - TipRanks
Enovis Corporation (NYSE:ENOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Conflicted on These Industrial Goods Names: Carrier Global (CARR), BrightView Holdings (BV) and Enovis (ENOV) - The Globe and Mail
Enovis Corporation’s Strong Q1 2025 Earnings Call - TipRanks
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating - marketscreener.com
JMP Securities Cuts Enovis (NYSE:ENOV) Price Target to $55.00 - Defense World
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
Analysts Offer Insights on Industrial Goods Companies: Enovis (ENOV), Boeing (BA) and Arlo Technologies (ARLO) - The Globe and Mail
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Enovis stock price target cut to $55 by JMP Securities - Investing.com South Africa
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis: Q1 Earnings Snapshot - New Haven Register
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges - Yahoo Finance
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges By GuruFocus - Investing.com Canada
Enovis Corporation Reports Strong Q1 2025 Growth - TipRanks
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Transcript : Enovis Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Enovis CORP SEC 10-Q Report - TradingView
Enovis reports Q1 adjusted EPS 81c, consensus 74c - TipRanks
Earnings call transcript: Enovis Q1 2025 earnings beat expectations, stock drops - Investing.com Nigeria
Enovis: Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating - TipRanks
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs By Investing.com - Investing.com South Africa
Enovis stock down on reduced earnings forecast, $20M tariff impact - MassDevice
Enovis Q1 Adjusted Earnings, Sales Rise; Updates 2025 Outlook - marketscreener.com
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $55 - GuruFocus
Enovis Announces First Quarter 2025 Results | ENOV Stock News - GuruFocus
ENOV Surpasses Q1 Revenue Projections with Robust Performance | - GuruFocus
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $559M, EPS Misses with -$0.98 - GuruFocus
Enovis shares fall nearly 5% as Q1 revenue misses estimates, guidance disappoints - Investing.com Nigeria
Enovis earnings beat by $0.07, revenue fell short of estimates - Investing.com
Enovis Corporation Q1 2025 Financial Results - TradingView
Enovis Announces First Quarter 2025 Results - The Manila Times
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Earnings Flash (ENOV) ENOVIS CORPORATION Reports Q1 Adjusted EPS $0.81, vs. FactSet Est of $0.74 - marketscreener.com
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):